Gabe Scannapieco Discusses FDA and DOJ Enforcement Priorities on FDA Watch Podcast

AGG Life Sciences industry team co-chair Gabe Scannapieco joined the FDA Watch Podcast to discuss current enforcement priorities across FDA and the U.S. Department of Justice (“DOJ”).

During the conversation, Gabe examined how FDA and DOJ coordinate enforcement efforts, recent compliance trends affecting FDA-regulated industry, and the government’s increasing focus on corporate accountability. Drawing on his experience as a former assistant director at the DOJ Consumer Protection Branch, Gabe explained how enforcement priorities continue to affect pharmaceutical, medical device, biotechnology, and other life sciences companies.

Gabe also provided practical compliance considerations for companies responding to government investigations, regulatory inquiries, and enforcement activity. He emphasized that organizations should maintain strong compliance programs and proactively evaluate potential areas of risk before issues become enforcement matters.

To listen to the full podcast, please click here.